<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000117> "Person:Alan Ruttenberg" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000111> "informing investigator of subject study arm" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000116> "09/28/2009 Alan Ruttenberg. This and the class informing-subject-of-study-arm are defined in order to solve the question of how to represent single and double blind experiments. To represent the aspect of double blinding pertaining to investigators, we say that the study execution doesn't include any processes of this sort" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0000011> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000232> "2009/09/28 Alan Ruttenberg. Fucoidan-use-case" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://www.w3.org/2000/01/rdf-schema#label> "informing investigator of subject study arm" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B3390bfea989617eb1902f053d24b5842 <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://purl.obolibrary.org/obo/IAO_0000115> "A process in which an investigator is made aware of which study arm that a patient is participating in, for example whether they are receiving a placebo or a treatment with an investigational compound." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000804> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://www.w3.org/2000/01/rdf-schema#label> "informing subject of study arm" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000232> "2009/09/28 Alan Ruttenberg. Fucoidan-use-case" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0000011> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000111> "informing subject of study arm" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000120> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:Bc86030593ee2c5c49c2633258ad9950a <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000117> "Person:Alan Ruttenberg" <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000115> "A process in which the subject is made aware of which study arm they are participating in, for example whether they are receiving a placebo or a treatment with an investigational compound." <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0000842> <http://purl.obolibrary.org/obo/IAO_0000116> "09/28/2009 Alan Ruttenberg. This and the class informing-investigator-of-study-arm are defined in order to solve the question of how to represent single and double blind experiments. To represent the aspect of blinding pertaining to subjects (happens in single and double blinding) we say that that the study execution doesn't include any processes of this sort" <http://purl.obolibrary.org/obo/obi.owl> .
